메뉴 건너뛰기




Volumn 17, Issue 5, 2010, Pages 491-501

Predicting the risk of cardiovascular disease in HIV-infected patients: The Data collection on Adverse Effects of Anti-HIV Drugs Study

Author keywords

Antiretroviral drugs; cardiovascular risk; HIV; prediction model

Indexed keywords

ABACAVIR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INDINAVIR; LOPINAVIR PLUS RITONAVIR;

EID: 78049258742     PISSN: 17418267     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJR.0b013e328336a150     Document Type: Article
Times cited : (319)

References (45)
  • 1
    • 1642403331 scopus 로고    scopus 로고
    • Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men
    • Mary-Krause M, Cotte L, Simon A, Partisani M, Costagliola D. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS 2003; 17:2479-2486.
    • (2003) AIDS , vol.17 , pp. 2479-2486
    • Mary-Krause, M.1    Cotte, L.2    Simon, A.3    Partisani, M.4    Costagliola, D.5
  • 3
    • 13944282290 scopus 로고    scopus 로고
    • Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients
    • Iloeje U, Yuan Y, L'Italien G, Mauskopf J, Holmberg S, Moorman A, et al. Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients. HIV Med 2005; 6:37-44.
    • (2005) HIV Med , vol.6 , pp. 37-44
    • Iloeje, U.1    Yuan, Y.2    L'Italien, G.3    Mauskopf, J.4    Holmberg, S.5    Moorman, A.6
  • 4
    • 34247537169 scopus 로고    scopus 로고
    • Risk of myocardial infarction in association with different classes of antiretroviral drugs
    • The D:A:D Study group
    • The D:A:D Study group. Risk of myocardial infarction in association with different classes of antiretroviral drugs. N Engl J Med 2007; 356:1723-1735.
    • (2007) N Engl J Med , vol.356 , pp. 1723-1735
  • 5
    • 42649130015 scopus 로고    scopus 로고
    • Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: A multi-cohort collaboration
    • Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, et al. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet 2008; 371:1417-1426.
    • (2008) Lancet , vol.371 , pp. 1417-1426
    • Sabin, C.A.1    Worm, S.W.2    Weber, R.3    Reiss, P.4    El-Sadr, W.5    Dabis, F.6
  • 6
    • 60649109560 scopus 로고    scopus 로고
    • Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients
    • Strategies for Management of Anti-Retroviral Therapy/INSIGHT and DAD Study Groups
    • Strategies for Management of Anti-Retroviral Therapy/INSIGHT and DAD Study Groups. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients. AIDS 2008; 22:F17-F24.
    • (2008) AIDS , vol.22
  • 7
    • 75649093029 scopus 로고    scopus 로고
    • Risk of myocardial infarction in HIV patients exposed to specific antiretroviral drugs from the three major drug classes: The D:A:D study
    • Worm SW, Sabin C, Weber R, Reiss P, El-Sadr W, Dabis F, et al. Risk of myocardial infarction in HIV patients exposed to specific antiretroviral drugs from the three major drug classes: the D:A:D study. J Infect Dis 2009; 201:318-330.
    • (2009) J Infect Dis , vol.201 , pp. 318-330
    • Worm, S.W.1    Sabin, C.2    Weber, R.3    Reiss, P.4    El-Sadr, W.5    Dabis, F.6
  • 8
    • 33645467423 scopus 로고    scopus 로고
    • The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: Comparison with observed events in the D:A:D Study
    • Law MG, Friis-Moller N, El-Sadr WM, Weber R, Reiss P, d'Arminio MA, et al. The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study. HIV Med 2006; 7:218-230.
    • (2006) HIV Med , vol.7 , pp. 218-230
    • Law, M.G.1    Friis-Moller, N.2    El-Sadr, W.M.3    Weber, R.4    Reiss, P.5    D'Arminio, M.A.6
  • 10
    • 0345064200 scopus 로고    scopus 로고
    • Combination antiretroviral therapy and the risk of myocardial infarction
    • The D:A:D Study group
    • The D:A:D Study group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349:1993-2003.
    • (2003) N Engl J Med , vol.349 , pp. 1993-2003
  • 12
    • 0028298802 scopus 로고
    • Myocardial infarction and coronary deaths in the World Health Organization MONICA Project Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents
    • Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90:583-612.
    • (1994) Circulation , vol.90 , pp. 583-612
    • Tunstall-Pedoe, H.1    Kuulasmaa, K.2    Amouyel, P.3    Arveiler, D.4    Rajakangas, A.M.5    Pajak, A.6
  • 13
    • 78049261674 scopus 로고    scopus 로고
    • WHO MONICA Project Accessed 28 October 2009
    • WHO MONICA Project. MONICA Manual, part IV, Event Registration. [Accessed 28 October 2009], at (http:/www.ktl.fi/publications/monica/manual/part4/iv-1. htm). 1999.
    • (1999) MONICA Manual Part IV Event Registration
  • 15
    • 70349769521 scopus 로고    scopus 로고
    • Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients
    • Hsue PY, Hunt PW, Wu Y, Schnell A, Ho JE, Hatano H, et al. Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients. AIDS 2009; 23:2021-2027.
    • (2009) AIDS , vol.23 , pp. 2021-2027
    • Hsue, P.Y.1    Hunt, P.W.2    Wu, Y.3    Schnell, A.4    Ho, J.E.5    Hatano, H.6
  • 16
    • 72849149643 scopus 로고    scopus 로고
    • Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-lamivudine: A randomized, 96-week trial
    • Martin A, Bloch M, Amin J, Baker D, Cooper DA, Emery S, Carr A. Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-lamivudine: a randomized, 96-week trial. Clin Infect Dis 2009; 49:1591-1601.
    • (2009) Clin Infect Dis , vol.49 , pp. 1591-1601
    • Martin, A.1    Bloch, M.2    Amin, J.3    Baker, D.4    Cooper, D.A.5    Emery, S.6    Carr, A.7
  • 17
    • 33747095777 scopus 로고    scopus 로고
    • Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: A case-control study
    • Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006; 368:647-658.
    • (2006) Lancet , vol.368 , pp. 647-658
    • Teo, K.K.1    Ounpuu, S.2    Hawken, S.3    Pandey, M.R.4    Valentin, V.5    Hunt, D.6
  • 18
    • 36549034768 scopus 로고    scopus 로고
    • Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths
    • Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet 2007; 370:1829-1839.
    • (2007) Lancet , vol.370 , pp. 1829-1839
    • Lewington, S.1    Whitlock, G.2    Clarke, R.3    Sherliker, P.4    Emberson, J.5    Halsey, J.6
  • 19
    • 0037079309 scopus 로고    scopus 로고
    • Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies
    • Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
    • (2002) Lancet , vol.360 , pp. 1903-1913
    • Lewington, S.1    Clarke, R.2    Qizilbash, N.3    Peto, R.4    Collins, R.5
  • 20
    • 70349212103 scopus 로고    scopus 로고
    • Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: A systematic review
    • Chirovsky DR, Fedirko V, Cui Y, Sazonov V, Barter P. Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review. Eur J Cardiovasc Prev Rehabil 2009; 16:404-423.
    • (2009) Eur J Cardiovasc Prev Rehabil , vol.16 , pp. 404-423
    • Chirovsky, D.R.1    Fedirko, V.2    Cui, Y.3    Sazonov, V.4    Barter, P.5
  • 21
    • 33644877269 scopus 로고    scopus 로고
    • HeartScore: A new web-based approach to European cardiovascular disease risk management
    • Thomsen T. HeartScore: a new web-based approach to European cardiovascular disease risk management. Eur J Cardiovasc Prev Rehabil 2005; 12:424-426.
    • (2005) Eur J Cardiovasc Prev Rehabil , vol.12 , pp. 424-426
    • Thomsen, T.1
  • 23
    • 0038748289 scopus 로고    scopus 로고
    • Prediction of coronary heart disease: A comparison between the Copenhagen risk score and the Framingham risk score applied to a Dutch population
    • De Visser CL, Bilo HJ, Thomsen TF, Groenier KH, Meyboom-de Jong B. Prediction of coronary heart disease: a comparison between the Copenhagen risk score and the Framingham risk score applied to a Dutch population. J Intern Med 2003; 253:553-562.
    • (2003) J Intern Med , vol.253 , pp. 553-562
    • De Visser, C.L.1    Bilo, H.J.2    Thomsen, T.F.3    Groenier, K.H.4    Meyboom-De Jong, B.5
  • 24
    • 0034945516 scopus 로고    scopus 로고
    • Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation
    • D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001; 286:180-187.
    • (2001) JAMA , vol.286 , pp. 180-187
    • D'Agostino Sr., R.B.1    Grundy, S.2    Sullivan, L.M.3    Wilson, P.4
  • 25
    • 1542506052 scopus 로고    scopus 로고
    • Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer
    • Royston P, Parmar MK, Sylvester R. Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer. Stat Med 2004; 23:907-926.
    • (2004) Stat Med , vol.23 , pp. 907-926
    • Royston, P.1    Parmar, M.K.2    Sylvester, R.3
  • 26
    • 4344585578 scopus 로고    scopus 로고
    • Development and validation of a prognostic model for survival time data: Application to prognosis of HIV positive patients treated with antiretroviral therapy
    • May M, Royston P, Egger M, Justice AC, Sterne JA. Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy. Stat Med 2004; 23:2375-2398.
    • (2004) Stat Med , vol.23 , pp. 2375-2398
    • May, M.1    Royston, P.2    Egger, M.3    Justice, A.C.4    Sterne, J.A.5
  • 27
    • 34250671221 scopus 로고    scopus 로고
    • Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease
    • Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007; 92:2506-2512.
    • (2007) J Clin Endocrinol Metab , vol.92 , pp. 2506-2512
    • Triant, V.A.1    Lee, H.2    Hadigan, C.3    Grinspoon, S.K.4
  • 29
    • 20444391714 scopus 로고    scopus 로고
    • A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study
    • Cooper JA, Miller GJ, Humphries SE. A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study. Atherosclerosis 2005; 181:93-100.
    • (2005) Atherosclerosis , vol.181 , pp. 93-100
    • Cooper, J.A.1    Miller, G.J.2    Humphries, S.E.3
  • 30
    • 0036668494 scopus 로고    scopus 로고
    • A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study
    • Thomsen TF, McGee D, Davidsen M, Jorgensen T. A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study. Int J Epidemiol 2002; 31:817-822.
    • (2002) Int J Epidemiol , vol.31 , pp. 817-822
    • Thomsen, T.F.1    McGee, D.2    Davidsen, M.3    Jorgensen, T.4
  • 31
    • 0038386036 scopus 로고    scopus 로고
    • Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study
    • Friis-Moller N, Weber R, Reiss P, Thiebaut R, Kirk O, d'Arminio MA, et al. Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. AIDS 2003; 17: 1179-1193.
    • (2003) AIDS , vol.17 , pp. 1179-1193
    • Friis-Moller, N.1    Weber, R.2    Reiss, P.3    Thiebaut, R.4    Kirk, O.5    D'Arminio, M.A.6
  • 32
    • 33645683288 scopus 로고    scopus 로고
    • HIV infection and tobacco smoking behaviour: Prospects for prevention? ANRS CO3 Aquitaine Cohort
    • Benard A, Tessier JF, Rambeloarisoa J, Bonnet F, Fossoux H, Neau D, et al. HIV infection and tobacco smoking behaviour: prospects for prevention? ANRS CO3 Aquitaine Cohort, 2002. Int J Tuberc Lung Dis 2006; 10:378-383.
    • (2002) Int J Tuberc Lung Dis , vol.10 , pp. 378-383
    • Benard, A.1    Tessier, J.F.2    Rambeloarisoa, J.3    Bonnet, F.4    Fossoux, H.5    Neau, D.6
  • 34
    • 2942748057 scopus 로고    scopus 로고
    • From Hayflick to Walford: The role of T cell replicative senescence in human aging
    • Effros RB. From Hayflick to Walford: the role of T cell replicative senescence in human aging. Exp Gerontol 2004; 39:885-890.
    • (2004) Exp Gerontol , vol.39 , pp. 885-890
    • Effros, R.B.1
  • 35
    • 61949441350 scopus 로고    scopus 로고
    • Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: The data collection on adverse events of Anti-HIV Drugs (D:A:D Study)
    • Worm SW, De WS, Weber R, Sabin CA, Reiss P, El-Sadr W, et al. Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the data collection on adverse events of Anti-HIV Drugs (D:A:D Study). Circulation 2009; 119:805-811.
    • (2009) Circulation , vol.119 , pp. 805-811
    • Worm, S.W.1    De, W.S.2    Weber, R.3    Sabin, C.A.4    Reiss, P.5    El-Sadr, W.6
  • 36
    • 0026073747 scopus 로고
    • Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? the Rancho Bernardo Study
    • Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991; 265:627-631.
    • (1991) JAMA , vol.265 , pp. 627-631
    • Barrett-Connor, E.L.1    Cohn, B.A.2    Wingard, D.L.3    Edelstein, S.L.4
  • 37
    • 4444382796 scopus 로고    scopus 로고
    • Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study
    • Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364:937-952.
    • (2004) Lancet , vol.364 , pp. 937-952
    • Yusuf, S.1    Hawken, S.2    Ounpuu, S.3    Dans, T.4    Avezum, A.5    Lanas, F.6
  • 38
    • 0033911688 scopus 로고    scopus 로고
    • Impact of diabetes on coronary artery disease in women and men: A meta-analysis of prospective studies
    • Lee WL, Cheung AM, Cape D, Zinman B. Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care 2000; 23:962-968.
    • (2000) Diabetes Care , vol.23 , pp. 962-968
    • Lee, W.L.1    Cheung, A.M.2    Cape, D.3    Zinman, B.4
  • 40
    • 36949026957 scopus 로고    scopus 로고
    • A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men
    • May M, Sterne JA, Shipley M, Brunner E, d'Agostino R, Whincup P, et al. A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men. Int J Epidemiol 2007; 36:1309-1318.
    • (2007) Int J Epidemiol , vol.36 , pp. 1309-1318
    • May, M.1    Sterne, J.A.2    Shipley, M.3    Brunner, E.4    D'Agostino, R.5    Whincup, P.6
  • 41
    • 70449389022 scopus 로고    scopus 로고
    • Changes in biomarkers of cardiovascular risk after a switch to abacavir in HIV-1-infected individuals receiving combination antiretroviral therapy
    • Kristoffersen US, Kofoed K, Kronborg G, Benfield T, Kjaer A, Lebech AM. Changes in biomarkers of cardiovascular risk after a switch to abacavir in HIV-1-infected individuals receiving combination antiretroviral therapy. HIV Med 2009; 10:627-633.
    • (2009) HIV Med , vol.10 , pp. 627-633
    • Kristoffersen, U.S.1    Kofoed, K.2    Kronborg, G.3    Benfield, T.4    Kjaer, A.5    Lebech, A.M.6
  • 43
    • 0037080037 scopus 로고    scopus 로고
    • A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: Results from the EuroSIDA study
    • Lundgren JD, Mocroft A, Gatell JM, Ledergerber B, d'Arminio MA, Hermans P, et al. A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA study. J Infect Dis 2002; 185:178-187.
    • (2002) J Infect Dis , vol.185 , pp. 178-187
    • Lundgren, J.D.1    Mocroft, A.2    Gatell, J.M.3    Ledergerber, B.4    D'Arminio, M.A.5    Hermans, P.6
  • 44
    • 33746500958 scopus 로고    scopus 로고
    • HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: A collaborative analysis
    • May MT, Sterne JA, Costagliola D, Sabin CA, Phillips AN, Justice AC, et al. HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet 2006; 368:451-458.
    • (2006) Lancet , vol.368 , pp. 451-458
    • May, M.T.1    Sterne, J.A.2    Costagliola, D.3    Sabin, C.A.4    Phillips, A.N.5    Justice, A.C.6
  • 45
    • 39049165369 scopus 로고    scopus 로고
    • European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV
    • Lundgren JD, Battegay M, Behrens G, De WS, Guaraldi G, Katlama C, et al. European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV. HIV Med 2008; 9:72-81.
    • (2008) HIV Med , vol.9 , pp. 72-81
    • Lundgren, J.D.1    Battegay, M.2    Behrens, G.3    De, W.S.4    Guaraldi, G.5    Katlama, C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.